Marinomed Biotech AG (WBO:MARI) FCF Yield % : -16.52 (As of Apr. 30, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Marinomed Biotech AG FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Marinomed Biotech AG's Trailing 12-Month Free Cash Flow is €-4.53 Mil, and Market Cap is €27.42 Mil. Therefore, Marinomed Biotech AG's FCF Yield % for today is -16.52%.

The historical rank and industry rank for Marinomed Biotech AG's FCF Yield % or its related term are showing as below:

WBO:MARI' s FCF Yield % Range Over the Past 10 Years
Min: -16.98 Med: -4.98 Max: -1.73
Current: -16.52

During the past 9 years, the highest FCF Yield % of Marinomed Biotech AG was -1.73%. The lowest was -16.98%. And the median was -4.98%.

WBO:MARI's FCF Yield % is ranked worse than
52.48% of 1551 companies
in the Biotechnology industry
Industry Median: -15.06 vs WBO:MARI: -16.52

Marinomed Biotech AG's FCF Margin % for the quarter that ended in Dec. 2023 was -18.99%.

Marinomed Biotech AG FCF Yield % Historical Data

The historical data trend for Marinomed Biotech AG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marinomed Biotech AG FCF Yield % Chart

Marinomed Biotech AG Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-6.79

-6.19

-4.44

-6.39

-10.47

Marinomed Biotech AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-6.95	-5.45	-10.13	-12.11	-3.46

Competitive Comparison of Marinomed Biotech AG's FCF Yield %

For the Biotechnology subindustry, Marinomed Biotech AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marinomed Biotech AG's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marinomed Biotech AG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Marinomed Biotech AG's FCF Yield % falls into.

Marinomed Biotech AG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Marinomed Biotech AG's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-4.657	/	44.495836
	=	-10.47%

Marinomed Biotech AG's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.385	*	4	/	44.495836
	=	-3.46%

Marinomed Biotech AG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Marinomed Biotech AG FCF Yield % Related Terms

Thank you for viewing the detailed overview of Marinomed Biotech AG's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Marinomed Biotech AG (WBO:MARI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marinomed Biotech AG (WBO:MARI) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

93Z:Germany

Address

Hovengasse 25, Korneuburg, AUT, 2100

Website

https://www.marinomed.com

Marinomed Biotech AG is a biopharmaceutical company focusing on the development of products in the field of respiratory and ophthalmological diseases. The products marketed by the company are based on its platform Carragelose and Marinosolv. The company develops products for cough, cold, influenza, allergic rhinitis, and ophthalmic diseases. Its product offerings include virus-blocking nasal sprays, virus-blocking decongestant nasal sprays, virus-blocking lozenges, and virus-blocking throat sprays. The company has two reportable segments which are Virology, Immunology, and other, the majority of revenue generates from the virology segment.

Marinomed Biotech AG (WBO:MARI) Headlines

No Headlines